Home FTC Settles Charges That Actavis's Proposed $8.5 Billion Acquisition...
 

Keywords :   


FTC Settles Charges That Actavis's Proposed $8.5 Billion Acquisition...

2013-09-28 10:29:05| Biotech - Topix.net

International drug manufacturer Actavis, Inc. has agreed to sell all rights and assets to four generic pharmaceuticals - three oral contraceptives and an osteoporosis treatment - to settle FTC charges that its proposed $8.5 billion acquisition of drug-maker Warner Chilcott plc would be anticompetitive.

Tags: proposed charges billion acquisition

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »